Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 805 results for "Treatment For Multiple Sclerosis"

Groundbreaking research into MS
Melbourne Age

Groundbreaking research into MS

The fact that Canberra woman Anne Hill will crawl to reach something if her legs fail her, shows that multiple sclerosis will never take her positive and persistent spirit, even if it has taken her family business and home. Her daughter, Laura ... Melbourne Age, 1 day ago
[x]  

Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA (Daclizumab) for Treatment of Multiple Sclerosis

CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.--(Business Wire)--The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for ...
 Digital Journal1 day ago BRIEF-European regulators recommends approval of Gileads new HIV treatment  Reuters UK1 day ago BIOGEN : and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA (Daclizumab) for Treatment of Multiple Sclerosis  4 Traders1 day ago BRIEF-Biogen and Abbvie receive positive opinion from the CHMP on zinbryta  Reuters UK1 day ago
[x]  

Menzies study looks at long-term benefits of multiple sclerosis treatment

Go to the Home screen by pressing the Home button or by unlocking your phone/iPad Select the Settings icon. Select Safari from the settings menu. Select 'accept cookies' from the safari menu. Select 'from visited' from the accept cookies ...
 Tasmania Mercury3 days ago New MS research will investigate whether drug treatment makes a long-term difference  Health Canal2 days ago Long-term MS treatment under microscope  NEWS.com.au3 days ago Edward Fox from the MS Clinic of Central Texas: Alemtuzumab's Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment VIDEO  HCPLive1 week ago
[x]  
International Business Times UK

Multiple sclerosis: Drug boosts myelin regeneration in mice raising hope of future treatments for MS

A new treatment for people suffering from multiple sclerosis (MS) may be on its way, scientists claim, after tests on mice showed promising results. The drug fluorosamine not yet approved for use in humans has the potential to boost myelin ...
 International Business Times UK4 days ago
Monthly Prescribing Reference

MedDay Reports Full Data from Pivotal Phase IIb/III MS-SPI / MS-ON Studies with MD1003 in Multiple Sclerosis at AAN

First drug capable of reversing disease progression in patients with progressive MS Extension phase data demonstrate sustained efficacy up to 2 years Both studies support efficacy specifically in patients with not-active progressive MS Best ...
 Bloomberg1 week ago MS Treatment Comparison  Monthly Prescribing Reference1 week ago MEDDAY : Reports Full Data from Pivotal Phase IIb/III MS-SPI / MS-ON Studies with MD1003 in Multiple Sclerosis at AAN  4 Traders1 week ago
[x]  

Update from the AAN Conference: Clinical Insights on Multiple Sclerosis Management from AAN 2016

NeuroSeries Live and MS experts to webcast a live-online, cme accredited update and Q&A on developments in Multiple Sclerosis Management from the American Academy of Neurology's annual conference. Join neurology peers for this complimentary session ...
 MySanAntonio1 week ago
[x]  
PRWeb

Medicationdiscountcard.com Provides Prescription Coupons to Patients With Multiple Sclerosis: In Tandem With New Treatments

Presription Savings Card Atlantic City, NJ (PRWEB) April 19, 2016 Over 400,000 Americans live with Multiple Sclerosis (MS) every day. There are an estimated 10,000 new cases diagnosed each year. New therapies that slow the progression of ...
 PRWeb1 week ago
Health Canal

Stem cell research reveals myelin repair capacity

Improved brain recovery in mouse models shows possible treatment pathways for diseases like cerebral palsy, multiple sclerosis In , Wenbin Deng and his colleagues present data showing that immature astroglial transplants, derived from human-induced ...
 Health Canal10 hours ago Medical research: Drug offers potential treatment for multiple sclerosis(Nature Communications)  Natureasia.com3 days ago

TECFIDERA® data highlights benefit of early treatment in relapsing-remitting multiple sclerosis

Biogen present new TECFIDERA (dimethyl fumarate) research at the 68th annual meeting of the American Academy of Neurology (AAN) in Vancouver, Canada. The data presented supports the value of dimethyl fumarate in the treatment of patients with ...
 Hospital Pharmacy Europe2 days ago

Physician Views Can biotin MedDay's MD1003 be used to treat non-active progressive multiple sclerosis?

At last year's annual meeting of the American Academy of Neurology (AAN) the cause of most excitement came from an unexpected source; positive Phase III data albeit in a relatively small number of patients demonstrating MedDay's ...
 FirstWord Pharma5 days ago Promising Results Reported for Pharmaceutical-Grade Biotin in Multiple Sclerosis Patients  PT Community1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Multiple Sclerosis
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less